Market Overview
The Global Oral Fluid Collection Tubes Market was valued at USD 111.2 Million in 2023 and is anticipated to reach a value of USD 209.3 Million by 2031 expanding at a CAGR of 8.3% between 2024 and 2031.
The Oral Fluid Collection Tubes market can be described as a niche category of a broader diagnostic and medical device industry that deals with the collection, preservation, and transport of oral fluid samples for diagnostic purposes. Saliva, or oral fluid, is being considered more often as the appropriate biofluid for making medical diagnostics due to the fact that it can be collected non-invasively, is easy to handle, and the results obtained reflect the levels of numerous biomarkers. These collection tubes are meant to ease the collection of saliva for tests concerning drug dependency, diseases, infections, etc., hormone balance, and genetics, among others. The market is propelled by an increase in the need for other forms of diagnostic methods that do not require invasive procedures, especially in drug testing and disease diagnosis departments. Oral fluid testing is less intrusive and more convenient than blood collection; therefore, it is suitable for routine tests, workplace drug analyses, and situations where the samples are collected from a distance. Biotechnology and molecular analysis have also increased the capacity and possibilities of saliva-based testing to increase the rate of correctness of outcomes.
To learn more about this report, request a free sample copy
Oral Fluid Collection Tubes Market Major Driving Forces
Rising Demand for Non-Invasive Diagnostic Methods: The need to use mouth swabs in oral fluid collection tubes has been boosted by their less invasive approach as compared to the use of a needle and vial in blood collection.
Advancements in Biotechnology and Molecular Diagnostics: Technological development continuously improves the effectiveness and versatility of saliva-based tests, expanding their fields of use and strengthening market demand.
Growing Prevalence of Drug Testing: These oral fluid collection tubes are widely used since the process of drug screening is a requirement in workplaces, sporting activities, and even in law enforcement.
Expansion of Telemedicine and Home-Based Healthcare: This is because the development of telemedicine and home-based healthcare services means that customers are seeking efficient, non-susceptible, and distant sample collection procedures.
Oral Fluid Collection Tubes Market Key Opportunities
Expansion into Emerging Markets: Growing investment in healthcare facilities and a growing consciousness about non-invasive diagnosis in developing economies offer enormous market prospects for oral fluid collection tubes.
Technological Innovations: Innovations in the oral fluid collection tubes with better samples’ retention and compatibility with digital health solutions can improve their performance and utilization.
Partnerships and Collaborations: It suggests forging partnerships with diagnostic labs, research institutions, and healthcare providers since it can lead to new development, increased product accessibility, and market penetration.
Oral Fluid Collection Tubes Market Key Trends
· Higher use of non-invasive diagnostic techniques.
· New developments in salivary biosensor systems.
· High demand for home testing and work-from-home kits.
· Incorporation of oral fluid testing with telemedicine services.
· The growing role of drug and alcohol testing.
· Increase of new smp applications in genetic and hormone analysis.
· Great importance was placed on the delivery and assessment of preventive healthcare and frequent check-ups.
· Manufacturing and designing of environmentally conscious and sustainable collection tubes
· Innovation of diagnostic kits that can fit specific patients’ needs.
· Improvements in the methods of sample preservation
· Infectious disease testing, other than COVID, to increase market share.
· Greater reliance on regulation and standardization.
Region-wise Market Insights
North America accounted for the largest market share at 39.2% in 2023 whereas, Asia Pacific is expected to register the fastest growth, expanding at a CAGR of 8.6% between 2024 and 2031.
To learn more about this report, request a free sample copy
North America holds the major share in the oral fluid collection tubes market, mainly due to increased usage of diagnostic products, a well-developed healthcare sector, and strict drug testing norms in the USA and Canada. Europe stands second, closely, owing to its strong market across the likes of Germany, the United Kingdom, and France, where there is a growing trend towards regular or preventive health check-ups. In Asia-Pacific specifically, the market has enormous potential to grow further with the advancement of the health care sector, the realization of higher disposable income, and the advantage of non-invasive testing methods, which is evident in countries such as China, India, and Japan. Rising cases of diseases, benefits offered by the government in this sector, and increasing health consciousness among people fuel the regional market in Asia-Pacific. Latin America, the Middle East, and Africa are considered to be the growth markets. Oral fluid collection tubes are taking root in countries within Latin America, such as Brazil and Mexico, due to the rising level of health consciousness and advanced diagnostic processes. In the Middle East and Africa, industry extension and development, investment in healthcare facilities, and progress in improving disease diagnosis and monitoring help increase demand, although the region can be disadvantageous in terms of infrastructural development and economic stability.
Market Competition Landscape
The oral fluid collection tubes market is highly competitive, where a number of large medical device companies and some emerging startups are working. The key players, including OraSure Technologies, Abbott Laboratories, and Quest Diagnostics, currently hold the largest market share due to their business strategy implementation, which includes a broad product portfolio offering, a well-established distribution channel, and robust R&D investments. These industry players use an innovative approach and market influence to ensure that they stand out from the competition by providing accurate and efficient oral fluid collection systems that meet diagnostic needs. Apart from those key companies, hundreds of other small-scale and start-up organizations have joined the market, not only creating competition but also inspiring innovations. These emerging players are more involved in refining and bringing down the production costs of innovations, the primary markets for which are home care testing and individual diagnosis. Key players in the global oral fluid collection tubes market implement various organic and inorganic strategies to strengthen and improve their market positioning. Prominent players in the market include:
· OraSure Technologies
· Abbott Laboratories
· Quest Diagnostics
· Neogen Corporation
· QIAGEN
· Thermo Fisher Scientific
· Promega Corporation
· Grifols
· Salimetrics
· SARSTEDT AG & Co.
· OraSure Technologies
· Fisher Scientific
· Spectrum Solutions
· Immunodiagnostic Systems Holdings PLC
· Luminex Corporation
Report Attribute/Metric |
Details |
Market Revenue in 2023 |
USD 111.2 Million |
Market Revenue in 2031 |
USD 209.3 Million |
CAGR (2024 – 2031) |
8.3% |
Base Year |
2023 |
Forecast Period |
2024 – 2031 |
Historical Data |
2019 to 2023 |
Forecast Unit |
Value (US$ Mn) |
Key Report Deliverable |
Revenue Forecast, Growth Trends, Market Dynamics, Segmental Overview, Regional and Country-wise Analysis, Competition Landscape |
Segments Covered |
· By Product Type (General-Purpose, Drug Testing, Genetic Testing, Infectious Disease Testing) · By End User (Hospitals, Diagnostic Laboratories, Research Institutes, Home Care Settings) · By Application (Clinical Diagnostics, Forensic Testing, Research Applications) · By Distribution Channel (Online, Offline) |
Geographies Covered |
North America: U.S., Canada and Mexico Europe: Germany, France, U.K., Italy, Spain, and Rest of Europe Asia Pacific: China, India, Japan, South Korea, Southeast Asia, and Rest of Asia Pacific South America: Brazil, Argentina, and Rest of Latin America Middle East & Africa: GCC Countries, South Africa, and Rest of Middle East & Africa |
Key Players Analyzed |
OraSure Technologies, Abbott Laboratories, Quest Diagnostics, Neogen Corporation, QIAGEN, Thermo Fisher Scientific, Promega Corporation, Grifols, Salimetrics, SARSTEDT AG & Co., Fisher Scientific, Spectrum Solutions, Immunodiagnostic Systems Holdings PLC, Luminex Corporation. |
Customization & Pricing |
Available on Request (10% Customization is Free) |